Clinical Trial Update: Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nanoliposomal irinotecan, oxaliplatin, and capecitabine as conversion therapy for locally advanced colorectal cancer is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Onivyde (irinotecan hydrochloride liposome injection)
• Xeloda (capecitabine)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING